These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23886402)

  • 1. Trajectories of individual symptoms in remitters versus non-remitters with depression.
    Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
    J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
    Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
    Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
    Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
    Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
    Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
    Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
    Funaki K; Nakajima S; Suzuki T; Mimura M; Uchida H
    J Clin Pharmacol; 2016 Sep; 56(9):1111-9. PubMed ID: 26813241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
    Shiroma PR; Drews MS; Geske JR; Mrazek DA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.
    Brown ES; Murray M; Carmody TJ; Kennard BD; Hughes CW; Khan DA; Rush AJ
    Ann Allergy Asthma Immunol; 2008 May; 100(5):433-8. PubMed ID: 18517074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
    Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
    J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.
    Kennedy SH; Lam RW; Rotzinger S; Milev RV; Blier P; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Giacobbe P; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; McInerney S; MacQueen GM; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Sassi RB; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Yu J; Uher R;
    J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30840787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
    Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
    Gaynes BN; Rush AJ; Trivedi MH; Wisniewski SR; Balasubramani GK; McGrath PJ; Thase ME; Klinkman M; Nierenberg AA; Yates WR; Fava M
    J Gen Intern Med; 2008 May; 23(5):551-60. PubMed ID: 18247097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
    Denninger JW; van Nieuwenhuizen AO; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ; Gollan JK; Pizzagalli DA; Fava M
    J Nerv Ment Dis; 2011 Oct; 199(10):807-10. PubMed ID: 21964277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
    Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
    Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
    Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
    McClintock SM; Husain MM; Wisniewski SR; Nierenberg AA; Stewart JW; Trivedi MH; Cook I; Morris D; Warden D; Rush AJ
    J Clin Psychopharmacol; 2011 Apr; 31(2):180-6. PubMed ID: 21346613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.